Evidence map›Paper›PMID 41591555›Full record

SynthesisAnnals of hematology2026

Pulmonary thromboembolism in Glanzmann Thrombasthenia: a case report and systematic literature review.

Tayebe Mohammad Alizade, Reihaneh Karimi, Hossein Kazemizadeh, Niloofar Khoshnam Rad

Abstract readCase ReportsSystematic Review
In one paragraph

Synthesis in Annals of hematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tayebe Mohammad AlizadeThoracic Research Center, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Reihaneh KarimiDepartment of Internal Medicine, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Hossein KazemizadehThoracic Research Center, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Niloofar Khoshnam RadThoracic Research Center, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran. Kh.niloofar@yahoo.com.ORCID http://orcid.org/0000-0001-6700-3570

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glanzmann Thrombasthenia (GT) is a congenital platelet disorder characterized by a life-long bleeding tendency, historically considered protective against thrombosis. This report describes a rare case of pulmonary embolism (PE) in a patient with GT, challenging this assumption and highlighting a critical management paradox. A 55-year-old woman with GT underwent elective cervical discectomy. Her perioperative hemostatic regimen included a single prophylactic dose of recombinant Factor VIIa (90 µg/kg), platelet transfusions (preoperative and daily for 3 days), and tranexamic acid. Two months postoperatively, she presented with hemoptysis. CT pulmonary angiography confirmed bilateral segmental and subsegmental PE with pulmonary infarctions. Anticoagulation with apixaban was initiated, leading to symptom resolution and thrombus regression. Therapy was discontinued after four months following a spontaneous hemarthrosis, which was managed successfully. Provoked PE can occur in GT patients following major surgery and hemostatic support. Apixaban was effective for short-term treatment, but the subsequent bleeding complication highlights the narrow therapeutic window and the need to limit anticoagulation duration in this population.

Indexed as

Pulmonary EmbolismThrombastheniaAnticoagulantsFactor VIIaFemaleHumansMiddle AgedPlatelet TransfusionPyrazolesPyridonesRecombinant ProteinsTranexamic AcidAnticoagulantsapixabanFactor VIIaPyrazolesPyridonesrecombinant FVIIaRecombinant ProteinsTranexamic AcidAnticoagulantsDirect oral anticoagulantsGlanzmann thrombastheniaPostoperative complicationsPulmonary embolism

Identifiers

PMID41591555
PMCPMC12847078

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.